心力衰竭与高凝血液标志物识别房颤相关卒中
该前瞻性研究对429例缺血性卒中患者进行病因学检查,其中103例为房颤相关卒中;房颤相关卒中患者NT-proBNP(1867 vs 263 pg/ml)和D-dimer(1.1 vs 0.6 µg/ml)更高、AT-III更低(89% vs 94%)。NT-proBNP ≥505 pg/ml区分房颤相关与非心源性卒中的敏感度93%、特异度72%;在143例初始隐源性卒中患者中,该阈值正确预测了14例监测发现房颤者中的12例(86%,阴性预测值98%)。
要点
- NT-proBNP ≥505 pg/ml有助于从隐源性卒中患者中筛选需延长心电监测以发现隐匿性房颤者。
- NT-proBNP低于505 pg/ml时阴性预测值高,提示房颤可能性低。
- D-dimer与AT-III对房颤相关卒中的判别价值有限。
核心结论
- NT-proBNP与房颤相关卒中存在关联,高凝标志物关联较弱。
- NT-proBNP有助于筛选隐源性卒中患者立即接受延长心电监测以检出隐匿性房颤。
研究设计与样本
- 前瞻性研究,1年内对卒中单元连续收治的缺血性卒中患者按既定流程进行病因学检查。
- 共429例患者,其中房颤相关卒中103例,非心源性卒中171例,初始隐源性卒中143例。
- 隐源性卒中患者接受住院期间延长心电监测(≥72小时),入院24小时内采血检测标志物。
主要发现
- 房颤相关卒中患者NT-proBNP为1867 pg/ml、D-dimer为1.1 µg/ml,高于非心源性卒中患者的263 pg/ml和0.6 µg/ml。
- 房颤相关卒中患者AT-III浓度为89%,低于非心源性卒中患者的94%。
- 143例初始隐源性卒中患者中14例在住院监测期间诊断房颤,NT-proBNP阈值正确预测其中12例(86%)。
关键数值与推荐
- NT-proBNP ≥505 pg/ml区分房颤相关与非心源性卒中:敏感度93%,特异度72%。
- D-dimer cutoff鉴别房颤相关卒中:敏感度61%,特异度58%。
- AT-III cutoff鉴别房颤相关卒中:敏感度53%,特异度69%。
- NT-proBNP ≥505 pg/ml预测隐源性卒中患者监测发现房颤的阴性预测值为98%。
临床怎么用
- 对初始隐源性卒中患者可检测NT-proBNP,≥505 pg/ml者优先安排延长心电监测以查找隐匿性房颤。
- NT-proBNP <505 pg/ml时房颤阴性预测值高,可辅助判断监测优先级。
- D-dimer与AT-III不宜单独用于筛选房颤相关卒中。
局限性
- 单中心前瞻性研究,样本量有限。
- 隐源性卒中患者中监测发现房颤者仅14例,预测指标结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Occult atrial fibrillation (AF) causes a relevant proportion of initially cryptogenic stroke (CS), but prolonged rhythm monitoring is difficult to apply to all such patients. We hypothesized that blood biomarkers indicating heart failure (NT-proBNP [N-terminal pro-brain natriuretic peptide]) and hypercoagulability (D-dimer, AT-III [antithrombin-III]) were associated with AF-related stroke and could serve to predict the likelihood of AF detection in CS patients early on. Methods- Over a 1-year period, we prospectively applied a defined etiologic work-up to all ischemic stroke patients admitted to our stroke unit. If no clear stroke cause was detected (CS), patients underwent extended in-hospital cardiac rhythm monitoring (≥72 hours). Blood to determine biomarker levels was drawn within 24 hours after admission. Results- Of 429 patients, 103 had AF-related stroke. Compared with noncardiac stroke patients (n=171), they had higher NT-proBNP (1867 versus 263 pg/ml) and D-dimer levels (1.1 versus 0.6 µg/ml), and lower AT-III concentration (89% versus 94%). NT-proBNP ≥505 pg/ml distinguished AF-related from noncardiac stroke with a sensitivity of 93% and a specificity of 72%. D-dimer and AT-III cutoffs had lower sensitivities (61% and 53%) and specificities (58% and 69%) for AF-related stroke. Of all initially 143 CS patients, 14 were diagnosed with AF during in-hospital monitoring. The preidentified NT-proBNP cutoff ≥505 pg/ml correctly predicted AF in 12 of them (86%, negative predictive value: 98%), while D-dimer and AT-III cutoffs were noncontributory. Conclusions- This study supports the association of NT-proBNP and to a lesser extent of hypercoagulation markers with AF-related stroke. NT-proBNP seems helpful in selecting CS patients for immediate extended cardiac rhythm monitoring to detect occult AF whereby levels <505 pg/ml seem to have a high-negative predictive value.
引用
- Kneihsl M, Gattringer T, Bisping E, et al. Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke. Stroke. 2019. PMID: 31216968. doi:10.1161/STROKEAHA.119.025339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。